DR. REDDY'S LABORATORIES LIMITED

🇱🇰Sri Lanka
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Bioequivalency Study of Divalproex Sodium DR Tablets, 500 mg of Dr.Reddy's Under Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Divalproex Sodium
First Posted Date
2010-05-27
Last Posted Date
2010-06-14
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
34
Registration Number
NCT01132170
Locations
🇮🇳

Bioserve Clinical Research Pvt. Ltd.,, Hyderabad, Andhra Pradesh, India

Bioequivalency Study of Ranitidine Tablets 300 mg of Dr. Reddy's Under Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Ranitidine
First Posted Date
2010-05-27
Last Posted Date
2010-06-09
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
24
Registration Number
NCT01131702
Locations
🇨🇦

Anapharm Inc., Montreal, Quebec, Canada

Bioequivalence Study of Primidone Tablets 50 mg of Dr. Reddy's Under Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Primidone
First Posted Date
2010-05-27
Last Posted Date
2010-05-27
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
24
Registration Number
NCT01132040
Locations
🇮🇳

Bioserve Clinical Research Pvt. Ltd,, HYD, Andhra Pradesh, India

Bioavailability Study of Tacrolimus Capsules, 5 mg of Dr. Reddy's Under Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Tacrolimus Capsules
First Posted Date
2010-05-27
Last Posted Date
2010-06-14
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
40
Registration Number
NCT01131988
Locations
🇮🇳

BA Research India Limited, Ahmedabad, Gujrat, India

Bioequivalence Study of Dr. Reddy's Laboratories Limited Fexofenadine Hydrochloride 180 mg Tablets Under Fed Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Fexofenadine
First Posted Date
2010-02-10
Last Posted Date
2010-02-10
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
30
Registration Number
NCT01066767
Locations
🇨🇦

Anapharm Inc.,, Sainte-Foy Quebec, Canada

Bioequivalence Study of Tizanidine HCl 4mg Tablets of Dr.Reddy's Under Fed Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Tizanidine
First Posted Date
2010-02-10
Last Posted Date
2010-02-10
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
24
Registration Number
NCT01065987
Locations
🇨🇦

Anapharm Inc., Sainte-Foy (Quebec), Canada

Bioequivalence Study of Dr.Reddy's Fexofenadine Hydrochloride 180 mg Tablets Under Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Fexofenadine
First Posted Date
2010-02-10
Last Posted Date
2010-02-10
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
44
Registration Number
NCT01066754
Locations
🇨🇦

Anapharm Inc.,, Sainte-Foy Quebec, Canada

Carvedilol 25 mg Film-coated Tablets, Bioequivalence Study of Dr. Reddys Under Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Carvedilol
First Posted Date
2010-02-08
Last Posted Date
2010-02-08
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
36
Registration Number
NCT01064154

Risperidone Tablets, 1 mg Bioequivalence Study of Dr.Reddy's Under Fed Condition

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Risperidone
First Posted Date
2010-02-08
Last Posted Date
2010-02-08
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
26
Registration Number
NCT01064271

Cetirizine Hydrochloride Tablets, 10 mg Bioequivalence Study of Dr.Reddy's Under Fed Condition

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Cetirizine Hydrochloride
First Posted Date
2010-02-08
Last Posted Date
2010-02-08
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
30
Registration Number
NCT01064115
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy